David Joseph Bozym, II, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Neoplasm | 2 | 2018 | 1996 | 0.170 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2018 | 89 | 0.150 |
Why?
|
| Melanoma | 3 | 2024 | 5695 | 0.110 |
Why?
|
| Cancer Vaccines | 2 | 2018 | 1042 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 5336 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 2570 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2024 | 4746 | 0.080 |
Why?
|
| Neutrophils | 1 | 2020 | 3771 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7426 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 5836 | 0.060 |
Why?
|
| Jurkat Cells | 1 | 2018 | 738 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 2897 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 4163 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2017 | 1441 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4263 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1643 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 13400 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3665 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4408 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 4649 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 18967 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9378 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2024 | 65219 | 0.010 |
Why?
|
| Humans | 4 | 2024 | 766117 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 59868 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 30209 | 0.010 |
Why?
|
| Female | 1 | 2020 | 396233 | 0.000 |
Why?
|